Literature DB >> 9813897

Maintenance treatment of opiate addicts in Germany with medications containing codeine--results of a follow-up study.

M Krausz1, U Verthein, P Degkwitz, C Haasen, P Raschke.   

Abstract

AIMS: Outpatient maintenance treatment of opiate addicts with codeine/dihydrocodeine is a common approach in the treatment of drug addicts in Germany. This study was carried out to assess possible benefits of codeine maintenance in terms of patients' health stabilization, social rehabilitation and drug consumption.
DESIGN: Three-year follow-up study.
SETTING: Three practices of substituting physicians in large-city areas in Germany. PARTICIPANTS: Of a random sample of 297 people attending for opiate outpatient treatment in 1993, 199 were successfully followed up 3 years later. MEASUREMENTS: Measures of health, living conditions, employment, criminal activities and drug use were collected at baseline and follow-up. The data were based on standardized interviews and medical examinations by the attending doctors as well as on questionnaires from the patients.
FINDINGS: Based on a 67%-follow-up rate, after 3 years of codeine maintenance there was improvement in general health and mental problems. The living and working situation remained more or less unchanged and stabilized at a satisfactory level. The same applies to the consumption of drugs.
CONCLUSION: The patients' progress shown in this study was comparable to that achieved by methadone maintenance in similar geographical regions. Codeine has a weaker pharmacological effects and our results suggest that codeine maintenance treatment deserves more attention and controlled trials to assess the benefits compared with methadone (or other opioids).

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9813897     DOI: 10.1046/j.1360-0443.1998.93811614.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  6 in total

1.  A call for evidence-based medical treatment of opioid dependence in the United States and Canada.

Authors:  Bohdan Nosyk; M Douglas Anglin; Suzanne Brissette; Thomas Kerr; David C Marsh; Bruce R Schackman; Evan Wood; Julio S G Montaner
Journal:  Health Aff (Millwood)       Date:  2013-08       Impact factor: 6.301

2.  Scientific and political challenges in North America's first randomized controlled trial of heroin-assisted treatment for severe heroin addiction: rationale and design of the NAOMI study.

Authors:  Eugenia Oviedo-Joekes; Bohdan Nosyk; David C Marsh; Daphne Guh; Suzanne Brissette; Candice Gartry; Michael Krausz; Aslam Anis; Martin T Schechter
Journal:  Clin Trials       Date:  2009-06       Impact factor: 2.486

3.  Dihydrocodeine/Agonists for alcohol dependents.

Authors:  Albrecht Ulmer; Markus Müller; Bernhard Frietsch
Journal:  Front Psychiatry       Date:  2012-03-23       Impact factor: 4.157

4.  Substitution treatment for opioid addicts in Germany.

Authors:  Ingo Ilja Michels; Heino Stöver; Ralf Gerlach
Journal:  Harm Reduct J       Date:  2007-02-02

Review 5.  Comparison of drug abuse in Germany and China.

Authors:  Ingo Ilja Michels; Yu-Xia Fang; Dong Zhao; Li-Yan Zhao; Lin Lu
Journal:  Acta Pharmacol Sin       Date:  2007-10       Impact factor: 6.150

6.  Dihydrocodeine for detoxification and maintenance treatment in individuals with opiate use disorders.

Authors:  Tara Carney; Marie Claire Van Hout; Ian Norman; Siphokazi Dada; Nandi Siegfried; Charles Dh Parry
Journal:  Cochrane Database Syst Rev       Date:  2020-02-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.